Sokolove Law Now Taking Gabapentin Cases Linked to Dementia & Cognitive Decline
-
NFL Titans coach says gun incident was 'cry for help'
-
Russia 'ready' to resume trilateral talks but cool on Ukraine deal
-
Websites go dark as AI exposes critical security flaws
-
Meta beats expectations but legal penalties hit profit amid AI race
-
Man Utd humiliated as Arsenal deny Bayern in Champions League
-
X Community Notes 'failed' to flag US election falsehoods, study says
-
Low-budget Brewers and Rays seek first World Series title
-
Arsenal 'concerned' about Saka injury, says Arteta
-
Pitiful Man Utd display heaps pressure on Carrick
-
Rice rescues Arsenal draw at Bayern in Champions League
-
Ohtani surgery 'not on the table': Dodgers chief
-
Rice grabs Arsenal draw at Bayern in Champions League
-
eBay to slash 1,000 more jobs, around 9% of workforce
-
Carrick unconcerned over future despite 'unacceptable' Como loss
-
Villa tame Viking to stay perfect in Champions League
-
Real Madrid rout Leipzig to continue perfect European start
-
Tesla profits drop but top analyst estimates
-
Walmart welcomes AI agents as Anthropic launches its own
-
Angels drop Suzuki as manager after club's worst MLB season
-
Quebec separatist premier sworn in without royal presence
-
Washington orders US embassy staff, families to leave Saudi Arabia
-
UAE nominates official to lead UN
-
Musk's SpaceX results lift global stock markets
-
NFL boss Goodell welcomes probe into Hurts medical care
-
NFL boss Goodell: Comfort level 'very high' for Paris game
-
Musk threatens Democrats teeing up congressional probes
-
Fernandes laments 'mood of defeat' as Man Utd crumble in Como
-
In the Mexican town that makes emblematic Day of the Dead garlands
-
Maradona doctor was made 'scapegoat' for his death, Argentine court told
-
Protests banned in parts of Paris as Macron swipes at Trump
-
Man Utd thrashed by Como in Champions League horror show
-
Judge orders Meta to pay $25 bn to New Mexico in Cambridge Analytica case
-
UN experts urge Meta to safeguard political expression in Brazil election
-
Champagne puts cork in project to expand production area
-
Websites go dark worldwide as AI exposes critical security flaws
-
Canadian publisher says novelist Orelien used AI to write novel
-
Defense in Maradona death trial seeks acquittal of doctor
-
Trump faces fresh questions over ties to 'humanitarian' Putin
-
Jansen, Rabada put South Africa in sight of win over Australia
-
Hansen back in Ireland squad for Nations Championship
-
Low Rhine weighed on German growth: central bank
-
Kremlin sees little 'substance' in Ukraine peace ideas
-
OpenAI says its AI agents disabled their own safety monitors
-
Top Arab-Israeli election candidate tells AFP Netanyahu win would be 'catastrophe'
-
Alldritt returns as France call up seven newcomers for Nations Championship
-
South African rugby player's death due to 'aortic dissection'
-
UN issues call to arms to combat off-the-charts El Nino
-
France's Macron lands in Riyadh on surprise 'solidarity' visit
-
Nigeria Ebola case matches DR Congo strain
-
Around the world, far right blames immigrants for French protests
Sokolove Law Now Taking Gabapentin Cases Linked to Dementia & Cognitive Decline
National Law Firm Investigates Whether Manufacturers Hid the Risks of Gabapentin Use
BOSTON, MA / ACCESS Newswire / June 4, 2026 / Sokolove Law, one of the nation's leading personal injury and mass tort law firms, announced today that it is now accepting cases from patients who developed dementia or experienced significant cognitive decline after long-term use of gabapentin (Neurontin®).
Gabapentin is one of the most widely prescribed medications in the United States. While it is FDA-approved to treat certain types of nerve pain and seizures, it's also commonly prescribed off-label for conditions like back pain and migraines.
However, emerging research has raised serious concerns about a potential link between prolonged gabapentin use and cognitive impairment - including memory loss, confusion, and dementia.
Lawsuits allege that Pfizer, the drug's manufacturer, failed to adequately warn patients and physicians about these risks.
"Millions of Americans have been prescribed gabapentin, often for years, trusting that it was safe," said Ricky LeBlanc, Managing Attorney at Sokolove Law. "If ongoing research confirms that gabapentin can contribute to cognitive decline, patients and their families deserve clear answers about what was known, when it was known, and who should be held accountable."
Sokolove Law is currently reviewing potential cases involving individuals who took gabapentin for an extended period and subsequently received a diagnosis of dementia or Alzheimer's disease.
Affected patients and their families can receive a free, no-obligation case review to see if they may be able to take legal action. There is no cost to speak with the firm, and clients pay nothing unless compensation is secured on their behalf.
About Sokolove Law
Sokolove Law is a national personal injury law firm headquartered in Chestnut Hill, Massachusetts. Since 1979, the firm has helped people across the U.S. pursue justice and compensation in cases involving mesothelioma, birth injury, sexual abuse, nursing home neglect, and dangerous pharmaceuticals and devices, securing over $10 billion total. By helping clients nationwide, Sokolove Law aims to make the legal system accessible to everyone. Learn more at www.sokolovelaw.com.
Media Contact:
Audrey Fisher
[email protected]
SOURCE: Sokolove Law
View the original press release on ACCESS Newswire
F.Schneider--AMWN
